The National Institutes of Health today authorized the use of 13 new lines of human embryonic stem cells — produced by researchers at Children’s Hospital Boston and Rockefeller University — for use in federally financed experiments. It is the first such approval under a policy shift announced last March by President Obama.
RSS
Follow The Ticker through your favorite RSS reader.